GrowingStockReport.com

Hologic Inc. (NASDAQ:HOLX) and Amedisys Inc. (NASDAQ:AMED) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 

New York, NY -- (ReleaseWire) -- 06/28/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Hologic Inc. (NASDAQ:HOLX) and Amedisys Inc. (NASDAQ:AMED).

Hologic Inc. (NASDAQ:HOLX) a company that develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women closed up in its previous session (+1.37%) on 7,502,026 shares traded after Hologic Announced to Release Third Quarter Fiscal 2013 Operating Results on Monday, August 5, 2013. Hologic Inc. (NASDAQ:HOLX) is currently up (+9.1%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Hologic Inc. (NASDAQ:HOLX)

Amedisys Inc. (NASDAQ:AMED) a company that together with its subsidiaries, operates as a home health and hospice closed down in its previous session (-12.69%) on 3,076,604 shares traded after Amedisys has been downgraded to Underperform from Neutral at RW Baird. Amedisys Inc. (NASDAQ:AMED) is currently down (-40.38%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Amedisys Inc. (NASDAQ:AMED)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com